Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer

Схожие документы

• A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report
  по: Rino, Yasushi, et al.
  Опубликовано: (2010)
• Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: Phase II Study of S-1, S-1 plus Cisplatin, and Weekly Paclitaxel in Patients with Advanced Gastric Carcinoma
  по: Rino, Yasushi, et al.
  Опубликовано: (2008)
• Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma
  по: Yasushi Rino M.D., et al.
  Опубликовано: (2008-01-01)
• Using NU-KNIT® for hemostasis around recurrent laryngeal nerve during transthoracic esophagectomy with lymphadenectomy for esophageal cancer
  по: Rino, Yasushi, et al.
  Опубликовано: (2014)
• Visualization of blood supply route to the reconstructed stomach by indocyanine green fluorescence imaging during esophagectomy
  по: Rino, Yasushi, et al.
  Опубликовано: (2014)